1. Dihydroartemisinin derivative DC32 inhibits inflammatory response in osteoarthritic synovium through regulating Nrf2/NF-κB pathway
   Ya-Nan Li et al, 2019, International Immunopharmacology CrossRef
2. Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis
   Chong-Jie Wu et al, 2022, Arthritis Res Ther CrossRef
3. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking
   Liu Yang et al, 2022 CrossRef
4. Potential Therapeutic Mechanism of Radix Angelicae Biseratae and Dipsaci Radix Herb Pair against Osteoarthritis: Based on Network Pharmacology and Molecular Docking
   Yujiang Xi et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
5. P53: A Key Target in the Development of Osteoarthritis
   Wentao Ma et al, 2023, Mol Biotechnol CrossRef
6. Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy
   Yixuan Chen et al, 2024, Lupus CrossRef